Kovack Advisors, Inc. Dexcom Inc Transaction History

Kovack Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$80.99 - $107.93 $60,580 - $80,731	-748 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$84.79 - $104.74 $16,958 - $20,948	-200 Reduced 21.1%	748 $269,000
Q4 2020 Jan 14, 2021	SELL	$78.0 - $104.5 $89,544 - $119,966	-1,148 Reduced 54.77%	948 $350,000
Q3 2020 Nov 02, 2020	BUY	$95.51 - $112.95 $149,186 - $176,427	1,562 Added 292.51%	2,096 $864,000
Q2 2020 Jul 31, 2020	BUY	$62.68 - $105.34 $33,471 - $56,251	534 New	534 $216,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.